Director, Global Health Economics Lead, Oncology Business Unit
Takeda
June 29, 2026
Remote friendly (Boston, MA)
United States
$177,000 - $278,080 USD yearly
Market Access
Responsibilities
- Drive and realize value demonstration strategies for Takeda’s global oncology portfolio, leading cross-functional integration to accelerate market access and deliver differentiated, evidence-based pricing.
- Lead global health economics (HE) plan development, reimbursement strategy, and evidence communication; build and deploy best-practice tools and training.
- Mobilize and align cross-functional/cross-regional stakeholders (R&D, Market Access, LOCs) to integrate evidence requirements and accelerate value realization.
- Co-lead enterprise frameworks (e.g., Integrated Evidence Generation Plans [EGPs]) aligned with payer, HTA, and policy needs.
- Pioneer digital, data science, and AI-driven HEOR approaches; influence enterprise decisions and mentor emerging leaders.
- Shape global thought leadership (forums, policy discussions, consortia) and build partnerships with HTA, payers, academics, and clinical stakeholders.
Global Value Proposition / Evidence / Tools / Market Access / Communication
- Deliver differentiated evidence-based HE value propositions to drive HTA/payer decisions and patient access.
- Provide vision for evidence generation, including payer and real-world data needs; review advanced evidence needs (RWE, patient-centered outcomes).
- Advance HEOR/market access tools and capabilities (e.g., Value Platforms, Dossiers, VBC toolkits); support value-based contracting.
- Serve as enterprise expert/spokesperson; monitor HTA/reimbursement trends; lead global communication strategy.
Basic Qualifications/Requirements
- Doctorate (7+ years) / Master’s (9+ years) / Bachelor’s (12+ years) in healthcare industry; experience in global value proposition development; interactions with payers/HTA bodies/policymakers; patient-centered focus.
- Strong knowledge of global payers and ex-US HTA guidance (NICE, CADTH, PBAC, EU JCA); US Medicare Part D; ICER; emerging market reimbursement (e.g., China).
- Hands-on experience in health economics/HTA (tools, filings, SLRs, ITCs), statistical analyses, economic modeling; clinical/epidemiologic data; outcomes research (PROs).
- Leadership in matrixed organizations; strong written/oral communication; strategic thinking/problem solving; influencing and consensus-building; ability to translate technical content.
- 5–10% domestic/international travel may be required.
Preferred Qualifications
- Hematology and/or Oncology experience.
- Global HTA (including EU JCA) and direct HTA submission experience.
- Direct payer and/or Market Access experience; peer-reviewed publications.
Benefits (if explicitly provided)
- Short-term/long-term incentives (US) and medical/dental/vision, 401(k) match, disability, life insurance, tuition reimbursement, paid volunteer time off, holidays, well-being benefits; up to 80 hours sick time and up to 120 hours paid vacation for new hires.
- Drive and realize value demonstration strategies for Takeda’s global oncology portfolio, leading cross-functional integration to accelerate market access and deliver differentiated, evidence-based pricing.
- Lead global health economics (HE) plan development, reimbursement strategy, and evidence communication; build and deploy best-practice tools and training.
- Mobilize and align cross-functional/cross-regional stakeholders (R&D, Market Access, LOCs) to integrate evidence requirements and accelerate value realization.
- Co-lead enterprise frameworks (e.g., Integrated Evidence Generation Plans [EGPs]) aligned with payer, HTA, and policy needs.
- Pioneer digital, data science, and AI-driven HEOR approaches; influence enterprise decisions and mentor emerging leaders.
- Shape global thought leadership (forums, policy discussions, consortia) and build partnerships with HTA, payers, academics, and clinical stakeholders.
Global Value Proposition / Evidence / Tools / Market Access / Communication
- Deliver differentiated evidence-based HE value propositions to drive HTA/payer decisions and patient access.
- Provide vision for evidence generation, including payer and real-world data needs; review advanced evidence needs (RWE, patient-centered outcomes).
- Advance HEOR/market access tools and capabilities (e.g., Value Platforms, Dossiers, VBC toolkits); support value-based contracting.
- Serve as enterprise expert/spokesperson; monitor HTA/reimbursement trends; lead global communication strategy.
Basic Qualifications/Requirements
- Doctorate (7+ years) / Master’s (9+ years) / Bachelor’s (12+ years) in healthcare industry; experience in global value proposition development; interactions with payers/HTA bodies/policymakers; patient-centered focus.
- Strong knowledge of global payers and ex-US HTA guidance (NICE, CADTH, PBAC, EU JCA); US Medicare Part D; ICER; emerging market reimbursement (e.g., China).
- Hands-on experience in health economics/HTA (tools, filings, SLRs, ITCs), statistical analyses, economic modeling; clinical/epidemiologic data; outcomes research (PROs).
- Leadership in matrixed organizations; strong written/oral communication; strategic thinking/problem solving; influencing and consensus-building; ability to translate technical content.
- 5–10% domestic/international travel may be required.
Preferred Qualifications
- Hematology and/or Oncology experience.
- Global HTA (including EU JCA) and direct HTA submission experience.
- Direct payer and/or Market Access experience; peer-reviewed publications.
Benefits (if explicitly provided)
- Short-term/long-term incentives (US) and medical/dental/vision, 401(k) match, disability, life insurance, tuition reimbursement, paid volunteer time off, holidays, well-being benefits; up to 80 hours sick time and up to 120 hours paid vacation for new hires.